Ran Zheng

Ran Zheng

Direktor/Vorstandsmitglied bei CARIBOU BIOSCIENCES, INC.

Vermögen: - $ am 30.04.2024

61 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Ran Zheng

EinheitArt der EinheitIndustrie
Public Company Biotechnology 18
Subsidiary Pharmaceuticals: Major 5
Landmark Bio PBLLC
1
Private Company 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Ran Zheng

UnternehmenSektorVerknüpfte PersonenHauptposition
Biotechnology

John Curnutte

Director/Board Member

PFIZER, INC. Pharmaceuticals: Major

Dara Richardson-Heron

Corporate Officer/Principal

ARROWHEAD PHARMACEUTICALS, INC. Biotechnology

Steven Kanner

Corporate Officer/Principal

EXELIXIS, INC. Pharmaceuticals: Major

Alan Garber

Natalie Sacks

Director/Board Member

Chief Tech/Sci/R&D Officer

Electric Utilities

Dara Richardson-Heron

Chief Tech/Sci/R&D Officer

PTC THERAPEUTICS, INC. Pharmaceuticals: Major

Mark Rothera

Corporate Officer/Principal

PORTOLA PHARMACEUTICALS, INC. Pharmaceuticals: Major

John Curnutte

President

AEGERION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Mark Rothera

Corporate Officer/Principal

Miscellaneous Commercial Services

Rachel Haurwitz

Director/Board Member

Biotechnology

Ruhi Khan

Corporate Officer/Principal

College/University

Alan Garber

John Curnutte

Corporate Officer/Principal

Undergraduate Degree

SILENCE THERAPEUTICS PLC Miscellaneous Commercial Services

Mark Rothera

Chief Executive Officer

University of Cambridge College/University

Mark Rothera

Graduate Degree

Bryn Mawr College College/University

Natalie Sacks

Undergraduate Degree

University of British Columbia College/University

Nancy Whiting

Jason O’Byrne

Undergraduate Degree

Undergraduate Degree

INSEAD College/University

Mark Rothera

Masters Business Admin

University of California, Berkeley College/University

Steven Kanner

Rachel Haurwitz

Cindy Hayashi

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

University of California, Irvine College/University

Elaine Alambra

Cherry Thomas

Undergraduate Degree

Graduate Degree

General Government

Dara Richardson-Heron

Corporate Officer/Principal

Miscellaneous Commercial Services

Rachel Haurwitz

Director/Board Member

Services to the Health Industry

Dara Richardson-Heron

Chief Executive Officer

Barnard College College/University

Dara Richardson-Heron

Director/Board Member

Miscellaneous Commercial Services

Dara Richardson-Heron

Chief Executive Officer

Medical Specialties

Mark Rothera

President

Medical Specialties

John Curnutte

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

John Curnutte

President

SAGIMET BIOSCIENCES INC. Pharmaceuticals: Major

John Curnutte

Chief Executive Officer

Harvard Medical School College/University

Alan Garber

John Curnutte

Corporate Officer/Principal

Doctorate Degree

DIADEXUS, INC. Biotechnology

John Curnutte

Director/Board Member

Harvard T.H. Chan School of Public Health College/University

Alan Garber

Natalie Sacks

Corporate Officer/Principal

Graduate Degree

Medical/Nursing Services

Mark Rothera

Director/Board Member

The Hastings Center

Dara Richardson-Heron

Director/Board Member

Perelman School of Medicine College/University

Steven Altschuler

Natalie Sacks

Corporate Officer/Principal

Doctorate Degree

Stanford University School of Medicine College/University

John Curnutte

Corporate Officer/Principal

Harvard College College/University

Ruhi Khan

Rachel Haurwitz

Undergraduate Degree

Undergraduate Degree

The University of Miami Leonard M. Miller School of Medicine College/University

Steven Kanner

Doctorate Degree

INTELLIA THERAPEUTICS, INC. Biotechnology

Rachel Haurwitz

Founder

PLIANT THERAPEUTICS, INC. Biotechnology

John Curnutte

Director/Board Member

Biotechnology

Mark Rothera

Chief Executive Officer

Investment Managers

John Curnutte

Consultant / Advisor

SEER, INC. Biotechnology

Rachel Haurwitz

Director/Board Member

Biotechnology

Mark Rothera

President

VIRACTA THERAPEUTICS, INC. Biotechnology

Mark Rothera

Chief Executive Officer

New York University School of Medicine College/University

Dara Richardson-Heron

Doctorate Degree

Miscellaneous Commercial Services

Steven Kanner

Director/Board Member

Statistik

International

Vereinigte Staaten 43
Vereinigtes Königreich 4
Kanada 3
Frankreich 2

Sektoral

Health Technology 20
Consumer Services 16
Commercial Services 7
Health Services 4
Utilities 2

Operativ

Director/Board Member 71
Corporate Officer/Principal 61
Independent Dir/Board Member 30
Undergraduate Degree 22
Chief Executive Officer 20
  1. Börse
  2. Insiders
  3. Ran Zheng
  4. Unternehmensverbindungen